Sign in
Author
|
Conference
|
Journal
|
Organization
|
Year
|
DOI
Look for results that meet for the following criteria:
since
equal to
before
between
and
Search in all fields of study
Limit my searches in the following fields of study
Agriculture Science
Arts & Humanities
Biology
Chemistry
Computer Science
Economics & Business
Engineering
Environmental Sciences
Geosciences
Material Science
Mathematics
Medicine
Physics
Social Science
Multidisciplinary
Co-authors
(27)
Frederick L. Hall
2
Miquel Angel Segui (Miquel Ángel Seguí)
2
Sant P. Chawla
2
Manuel J. Munoz (Manuel J. Muñoz)
2
Victoria S Chua
2
Journals
(4)
MOL THER
2
J PHYSIOL BIOCHEM
1
ANN ONCOL
1
RADIOTHER ONCOL
1
Keywords
(17)
Embed
Subscribe
Academic
Authors
Lita Fernandez
Lita Fernandez,Oncology,Physiology
Edit
Lita Fernandez
Publications:
5
|
Citations:
4
Fields:
Oncology
,
Physiology
View FAQ about top research areas and Fields of study
Collaborated with
27 co-authors
from 2003 to 2011
|
Cited by
21 authors
Cumulative
Annual
Sort by:
Publications
(5)
BibTeX
|
RIS
|
RefWorks
Download
A RETROSPECTIVE REVIEW OF PATIENTS WITH SCCHN TREATED WITH INDUCTION CHEMOTHERAPY BETWEEN 1999–2008
T. Bontill
,
A. F. Aguilà
,
E. Mur
,
Y. Escamilla
,
L. Fernandez
,
M. Bonet
,
R. Roseli
,
J. M. Sole
,
E. Saigi
,
M. A. Segui
Journal:
Radiotherapy and Oncology - RADIOTHER ONCOL
, vol. 98, pp. S28-S28, 2011
Advanced Phase I/II Studies of Targeted Gene Delivery In Vivo: Intravenous Rexin-G for Gemcitabine-resistant Metastatic Pancreatic Cancer
(
Citations: 1
)
Sant P Chawla
,
Victoria S Chua
,
Lita Fernandez
,
Dorris Quon
,
William C Blackwelder
,
Erlinda M Gordon
,
Frederick L Hall
Journal:
Molecular Therapy - MOL THER
, vol. 18, no. 2, pp. 435-441, 2010
Phase I/II and Phase II Studies of Targeted Gene Delivery In Vivo: Intravenous Rexin-G for Chemotherapy-resistant Sarcoma and Osteosarcoma
(
Citations: 2
)
Sant P Chawla
,
Victoria S Chua
,
Lita Fernandez
,
Doris Quon
,
Andreh Saralou
,
William C Blackwelder
,
Frederick L Hall
,
Erlinda M Gordon
Journal:
Molecular Therapy - MOL THER
, vol. 17, no. 9, pp. 1651-1657, 2009
Phase I clinical trial of liposomal-encapsulated doxorubicin citrate and docetaxel, associated with trastuzumab, as neo-adjuvant treatment in stages II and IIIA, HER2-overexpressing breast cancer patients. GEICAM 2003-03 study
(
Citations: 1
)
A. Anton
,
A. Ruiz
,
M. A. Segui
,
L. Calvo
,
M. Munoz
,
J. Lao
,
F. Sancho
,
L. Fernandez
Journal:
Annals of Oncology - ANN ONCOL
, vol. 20, no. 3, pp. 454-459, 2008
Effects of S-adenosylmethionine on hepatic regeneration after partial hepatectomy in the rat
L. Fernández
,
V. Pérez
,
M. Muñoz
,
J. M. Corpa
,
M. Abad
,
M. T. Carbajo
Journal:
Journal of Physiology and Biochemistry - J PHYSIOL BIOCHEM
, vol. 59, no. 1, pp. 63-64, 2003
Sort by:
Citations
(4 times by 4 publications)
Systematic Therapy for Unresectable or Metastatic Soft-Tissue Sarcomas: Past, Present, and Future
Sherif S. Morgan
,
Lee D. Cranmer
Journal:
Current Oncology Reports
, vol. 13, no. 4, pp. 331-349, 2011
Phase II clinical trial of liposomal-encapsulated doxorubicin citrate and docetaxel, associated with trastuzumab, as neoadjuvant treatment in stages II and IIIA HER2-overexpressing breast cancer patients. GEICAM 2003-03 study
(
Citations: 1
)
A. Anton
,
A. Ruiz
,
A. Plazaola
,
L. Calvo
,
M. A. Segui
,
A. Santaballa
,
M. Munoz
,
P. Sanchez
,
A. Miguel
,
E. Carrasco
,
J. Lao
,
J. Camps
http://academic.research.microsoft.com/io.ashx?type=5&id=28888552&selfId1=54707940&selfId2=0&maxNumber=12&query=
Journal:
Annals of Oncology - ANN ONCOL
, vol. 21, no. 8, 2010
Noteworthy clinical case studies in cancer gene therapy: Tumor-targeted Rexin-G advances as an efficacious anti-cancer agent
ERLINDA M. GORDON
,
FREDERICK L. HALL
Journal:
International Journal of Oncology - INT J ONCOL
, vol. 36, no. 6, 2010
Gene Therapy for Sarcoma
Keila E. Torres
,
Raphael E. Pollock
Comments